Search
Displaying 381–390 of 705 for “retinitis clinical trial”
-
Ophthotech to Boost Development of Gene Therapy for Best Disease
Research NewsOphthotech Corporation, a biopharmaceutical company focused on the development of therapies for orphan retinal diseases and age-related macular degeneration, has announced an evolving, commercial partnership with the University of Pennsylvania and University of Florida to develop a gene therapy for Best disease caused by BEST1 mutations.
-
FFB Funding More than $2 Million in New Research
Research NewsSeventy scientists submitted requests for funding.
-
Persevering to Success with the Support of Family, Friends, and Faith
Beacon StoriesA story about living with retinitis pigmentosa.
-
CME — What It Is, and Why People with Retinal Diseases Should Know About It
Research NewsDr. Gerald Fishman discusses cystoid macular edema (CME), a potentially damaging accumulation of fluid in the retina affecting up to 32 percent of people with retinitis pigmentosa (RP).
-
Inspired by Progress in Usher Syndrome Research
Research NewsMark Pennesi, M.D., Ph.D., a Foundation-funded clinical researcher at the Casey Eye Institute, discusses the first human study of gene therapy for Usher syndrome type 1B.
-
The Invaluable Role of the Retinal Specialist
Research NewsUntil therapies become readily available, it’s important for patients and families to establish an ongoing relationship with a retinal specialist familiar with retinal degenerations.
-
Beacon Stories
Maverick, a determined and adventurous 11-year-old, was diagnosed with X-linked retinoschisis (XLRS) at age six, which led his family to find support and resources through the Foundation Fighting Blindness. Since his diagnosis, Mav continues to pursue his passions in sports and outdoor activities, inspiring his family with his resilience and positive attitude.
-
Eye on the Cure Podcast | Episode 90: Dr. Christina Ohnsman
Eye on the CureDr. Christina Ohnsman talks about Tern Therapeutics, a start-up company she co-founded to develop gene therapies for Batten disease and potentially other conditions.
-
Eye on the Cure Podcast | Episode 87: Dr. Philip Beales
Eye on the CureDr. Philip Beales, a co-founder of Axovia Therapeutics, talks about Bardet Biedl syndrome.
